We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc.

Greykasell Wealth Strategies Inc. acquired 708 shares of Regeneron Pharmaceuticals, valued at approximately $504,000. Other ...

Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

The fund outperformed its benchmark and peers for the final quarter and full year 2024, driven by positive stock selection.

Jones Financial Companies Lllp increased its stake in Regeneron Pharmaceuticals by 107.7% in Q4, now holding 812 shares.

This writer digs into the CRISPR gene-editing space, asking whether one particular penny stock is worth taking a punt on in his ISA.

NEW YORK, March 2, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) between November 2 ...

TARRYTOWN, N.Y. - Regeneron (NASDAQ:REGN) Pharmaceuticals, Inc. (NASDAQ: REGN), a prominent biotechnology company with a market capitalization of $75.2 billion and annual revenue of $14.2 billion ...

Drucker honored District 16’s seven Regeneron Science Talent Search semifinalists and finalists. The Regeneron Science Talent Search scholars were selected from nearly 2,500 entrants from 795 ...

In Q4, Intellia demonstrated significant progress ... Collaborations with entities like Regeneron enhance its clinical pipeline and revenue. However, R&D expenses rose to $116.9 million due ...